109 related articles for article (PubMed ID: 18096871)
21. Frequency of Alloicoccus otitidis, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae in children with otitis media with effusion (OME) in Iranian patients.
Khoramrooz SS; Mirsalehian A; Emaneini M; Jabalameli F; Aligholi M; Saedi B; Bazargani A; Taherikalani M; Borghaei P; Razmpa E
Auris Nasus Larynx; 2012 Aug; 39(4):369-73. PubMed ID: 21868180
[TBL] [Abstract][Full Text] [Related]
22. Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution.
Augustyniak D; Seredyński R; McClean S; Roszkowiak J; Roszniowski B; Smith DL; Drulis-Kawa Z; Mackiewicz P
Sci Rep; 2018 Mar; 8(1):4955. PubMed ID: 29563531
[TBL] [Abstract][Full Text] [Related]
23. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.
Tan TT; Riesbeck K
Expert Rev Vaccines; 2007 Dec; 6(6):949-56. PubMed ID: 18377357
[TBL] [Abstract][Full Text] [Related]
24. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
25. Moraxella catarrhalis Evades Host Innate Immunity via Targeting Cartilage Oligomeric Matrix Protein.
Liu G; Gradstedt H; Ermert D; Englund E; Singh B; Su YC; Johansson ME; Aspberg A; Agarwal V; Riesbeck K; Blom AM
J Immunol; 2016 Feb; 196(3):1249-58. PubMed ID: 26712944
[TBL] [Abstract][Full Text] [Related]
26. Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells.
Lafontaine ER; Wall D; Vanlerberg SL; Donabedian H; Sledjeski DD
Infect Immun; 2004 Nov; 72(11):6689-93. PubMed ID: 15501804
[TBL] [Abstract][Full Text] [Related]
27. The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain.
Lipski SL; Akimana C; Timpe JM; Wooten RM; Lafontaine ER
Infect Immun; 2007 Jan; 75(1):314-24. PubMed ID: 17088358
[TBL] [Abstract][Full Text] [Related]
28. Streptococcal otitis media: from epidemiology to pathogenesis.
Shulman ST; Tanz RR
Clin Infect Dis; 2005 Jul; 41(1):42-4. PubMed ID: 15937761
[No Abstract] [Full Text] [Related]
29. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
Wallrauch-Schwarz C; Milatovic D; Braveny I
Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
[TBL] [Abstract][Full Text] [Related]
30. Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance.
Forsgren A; Brant M; Riesbeck K
J Infect Dis; 2004 Jul; 190(2):352-5. PubMed ID: 15216472
[TBL] [Abstract][Full Text] [Related]
31. The Moraxella catarrhalis outer membrane protein CD contains two distinct domains specifying adherence to human lung cells.
Akimana C; Lafontaine ER
FEMS Microbiol Lett; 2007 Jun; 271(1):12-9. PubMed ID: 17391370
[TBL] [Abstract][Full Text] [Related]
32. Significance of Haemophilus spp. and Branhamella catarrhalis in upper respiratory tract infections.
Russo G; Stefani S; Oliveri S
J Chemother; 1991 Jan; 3 Suppl 1():15-8. PubMed ID: 12041752
[TBL] [Abstract][Full Text] [Related]
33. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
Doern GV
Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856
[TBL] [Abstract][Full Text] [Related]
34. Moraxella catarrhalis: from interactions with the host immune system to vaccine development.
Su YC; Singh B; Riesbeck K
Future Microbiol; 2012 Sep; 7(9):1073-100. PubMed ID: 22953708
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
36. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
37. Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity.
Nordström T; Blom AM; Tan TT; Forsgren A; Riesbeck K
J Immunol; 2005 Sep; 175(6):3628-36. PubMed ID: 16148107
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
[TBL] [Abstract][Full Text] [Related]
39. Surface-exposed adherence molecules of Streptococcus pneumoniae.
Hammerschmidt S
Methods Mol Biol; 2009; 470():29-45. PubMed ID: 19089373
[TBL] [Abstract][Full Text] [Related]
40. Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics.
Broides A; Dagan R; Greenberg D; Givon-Lavi N; Leibovitz E
Clin Infect Dis; 2009 Dec; 49(11):1641-7. PubMed ID: 19886799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
